Neratinib / 698387-09-6
Post Date: |
Aug 18,2016 |
Expiry Date: |
Aug 18,2017 |
Detailed Description: |
Cas No. :698387-09-6
Specs:98%min
Payment Method: T/T
Neratinib (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor with IC50 of 59 nM and 92 nM for HER2 and EGFR, respectively. |
CAS Registry Number: |
|
Synonyms: |
;(2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide;(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide;HKI-272; |
Molecular Formula: |
C30H29ClN6O3 |
Molecular Weight: |
557.0427 |
Molecular Structure: |
|
Company: |
Shanghai Biopharmaleader Co.,Ltd
[ China ]
|
Contact: |
Brenda Xu |
Tel: |
021-50180596 |
Fax: |
021-57758967 |
Email: |
brenda@biopharmaleader.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.